The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease

Journal of Nutritional Biochemistry

Volumn 19, Issue 10, 2008, Pages 643-654

  Erdmann, Kati ^a   Cheung, Belinda W Y ^a   Schröder, Henning ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Antihypertensive; Antioxidant; Antithrombotic; Bioactive peptides; Cardiovascular disease; Hypocholesterolemic hypotriglyceridemic

Indexed keywords

ANTIOBESITY AGENT; ANTIOXIDANT; BETA CASEIN; BETA CONGLYCININ; BETA LACTAGLOBULIN; BETA LACTOSIN A; BETA LACTOSIN B; BIOPURE GMP; BIOZATE; C12 PEPTIDE; CALPIS; CASEIN DP; CASOKININ; CHOLESTEBLOCK; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVOLUS; GLIADIN; GLOBULIN; GLYCININ; HYPOCHOLESTEROLEMIC AGENT; ISOLEUCINE; ISOLEUCYLPROLYLPROLINE; KAPPA CASEIN; LACTOFERRIN; LACTOKININ; LACTOSTATIN; LYSINE; MYOPENTAPEPTIDE A; NUTRACEUTICAL; OVALBUMIN; PEPTIDE SOUP; SITOSTEROL; SOYBEAN PROTEIN; THROMBOCYTE SLOWING FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALYLARGINYLISOLEUCYLARGINYLLEUCYLLEUCYLGLUTAMINYLARGINYLPHENYLALANYL ASPARAGINYLLYSYLARGINYLSERINE; VALYLPROLYLPROLINE; VALYLTYROSINE;

ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BIOLOGICAL ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; DIGESTION; FOOD PROCESSING; HEART INFARCTION; HUMAN; HYPERTENSION; IMMUNOMODULATION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MILK; NONHUMAN; OBESITY; PROPHYLAXIS; REVIEW; SOYBEAN; STROKE;

AMINO ACID SEQUENCE; ANTILIPEMIC AGENTS; ANTIOXIDANTS; ANTITHROMBINS; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; HUMANS; OBESITY; PEPTIDES; RISK FACTORS;

ANIMALIA;

EID: 51049097278     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2007.11.010     Document Type: Review

References (154)

1. Hartmann R., and Meisel H. Food-derived peptides with biological activity: from research to food applications. Curr Opin Biotechnol 18 (2007) 163-169
2. Kitts D.D., and Weiler K. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr Pharm Des 9 (2003) 1309-1323
3. Kovacs-Nolan J., Phillips M., and Mine Y. Advances in the value of eggs and egg components for human health. J Agric Food Chem 53 (2005) 8421-8431
4. Meisel H. Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers 43 (1997) 119-128
5. Korhonen H., and Pihlanto A. Food-derived bioactive peptides - opportunities for designing future foods. Curr Pharm Des 9 (2003) 1297-1308
6. Meisel H. Multifunctional peptides encrypted in milk proteins. Biofactors 21 (2004) 55-61
7. Meisel H., and FitzGerald R.J. Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharm Des 9 (2003) 1289-1295
8. Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 336 (1997) 1117-1124
9. Pfeuffer M., and Schrezenmeir J. Bioactive substances in milk with properties decreasing risk of cardiovascular diseases. Br J Nutr 84 Suppl 1 (2000) S155-S159
10. Severin S., and Wenshui X. Milk biologically active components as nutraceuticals: review. Crit Rev Food Sci Nutr 45 (2005) 645-656
11. Lopez A.D., and Murray C.C. The global burden of disease, 1990-2020. Nat Med 4 (1998) 1241-1243
12. Svetkey L.P., Simons-Morton D., Vollmer W.M., Appel L.J., Conlin P.R., Ryan D.H., et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 159 (1999) 285-293
13. Jeppesen J., Schaaf P., Jones C., Zhou M.Y., Chen Y.D., and Reaven G.M. Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women. Am J Clin Nutr 65 (1997) 1027-1033
14. Obarzanek E., Sacks F.M., Vollmer W.M., Bray G.A., Miller III E.R., Lin P.H., et al. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr 74 (2001) 80-89
15. Stamler J., Elliott P., Kesteloot H., Nichols R., Claeys G., Dyer A.R., et al. Inverse relation of dietary protein markers with blood pressure. Findings for 10,020 men and women in the INTERSALT Study. INTERSALT Cooperative Research Group. INTERnational study of SALT and blood pressure. Circulation 94 (1996) 1629-1634
16. Hu F.B., Stampfer M.J., Manson J.E., Rimm E., Colditz G.A., Speizer F.E., et al. Dietary protein and risk of ischemic heart disease in women. Am J Clin Nutr 70 (1999) 221-227
17. Appel L.J., Sacks F.M., Carey V.J., Obarzanek E., Swain J.F., Miller III E.R., et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 294 (2005) 2455-2464
18. Appel L.J. The effects of protein intake on blood pressure and cardiovascular disease. Curr Opin Lipidol 14 (2003) 55-59
19. Elliott P. Protein intake and blood pressure in cardiovascular disease. Proc Nutr Soc 62 (2003) 495-504
20. Hasler C.M. The changing face of functional foods. J Am Coll Nutr 19 (2000) 499S-506S
21. Roberfroid M.B. A European consensus of scientific concepts of functional foods. Nutrition 16 (2000) 689-691
22. Harris T., Cook E.F., Kannel W., Schatzkin A., and Goldman L. Blood pressure experience and risk of cardiovascular disease in the elderly. Hypertension 7 (1985) 118-124
23. Kannel W.B., and Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens Suppl 8 (1990) S3-S8
24. FitzGerald R.J., Murray B.A., and Walsh D.J. Hypotensive peptides from milk proteins. J Nutr 134 (2004) 980S-988S
25. Vercruysse L., Van Camp J., and Smagghe G. ACE inhibitory peptides derived from enzymatic hydrolysates of animal muscle protein: a review. J Agric Food Chem 53 (2005) 8106-8115
26. Yamamoto N. Antihypertensive peptides derived from food proteins. Inc Biopoly 43 (1997) 129-134
27. Nakamura Y., Yamamoto N., Sakai K., and Takano T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I_converting enzyme. J Dairy Sci 78 (1995) 1253-1257
28. Seppo L., Jauhiainen T., Poussa T., and Korpela R. A fermented milk high in bioactive peptides has a blood pressure_lowering effect in hypertensive subjects. Am J Clin Nutr 77 (2003) 326-330
29. Abubakar A., Saito T., Kitazawa H., Kawai Y., and Itoh T. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. J Dairy Sci 81 (1998) 3131-3138
30. Murakami M., Tonouchi H., Takahashi R., Kitazawa H., Kawai Y., Negishi H., et al. Structural analysis of a new anti_hypertensive peptide (beta_lactosin B) isolated from a commercial whey product. J Dairy Sci 87 (2004) 1967-1974
31. Kawasaki T., Seki E., Osajima K., Yoshida M., Asada K., Matsui T., et al. Antihypertensive effect of valyl_tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J Hum Hypertens 14 (2000) 519-523
32. Matsufuji H., Matsui T., Ohshige S., Kawasaki T., Osajima K., and Osajima Y. Antihypertensive effects of angiotensin fragments in SHR. Biosci Biotechnol Biochem 59 (1995) 1398-1401
33. Fujita H., and Yoshikawa M. LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 44 (1999) 123-127
34. Fujita H., Yokoyama K., and Yoshikawa M. Classification and antihypertensive activity of angiotensin I_converting enzyme inhibitory peptides derived from food proteins. J Food Sci 65 (2000) 564-569
35. Nakashima Y., Arihara K., Sasaki A., Mio H., Ishikawa S., and Itoh M. Antihypertensive Activities of Peptides Derived from Porcine Skeletal Muscle Myosin in Spontaneously Hypertensive Rats. J Food Sci 67 (2002) 434-437
36. Kodera T., and Nio N. Identification of an Angiotensin I_converting Enzyme Inhibitory Peptides from Protein Hydrolysates by a Soybean Protease and the Antihypertensive Effects of Hydrolysates in Spontaneously Hypertensive Model Rats. J Food Sci 71 (2006) C164-C173
37. Motoi H., and Kodama T. Isolation and characterization of angiotensin I_converting enzyme inhibitory peptides from wheat gliadin hydrolysate. Nahrung/Food 47 (2003) 354-358
38. FitzGerald R.J., and Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr 84 Suppl 1 (2000) S33-S37
39. Meisel H. Biochemical properties of peptides encrypted in bovine milk proteins. Curr Med Chem 12 (2005) 1905-1919
40. Matsufuji H., Matsui T., Seki E., Osajima K., Nakashima M., and Osajima Y. Angiotensin I-converting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle. Biosci Biotechnol Biochem 58 (1994) 2244-2245
41. Vermeirssen V., Van Camp J., and Verstraete W. Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br J Nutr 92 (2004) 357-366
42. Gardner M.L. Gastrointestinal absorption of intact proteins. Annu Rev Nutr 8 (1988) 329-350
43. Webb Jr. K.E. Intestinal absorption of protein hydrolysis products: a review. J Anim Sci 68 (1990) 3011-3022
44. Masuda O., Nakamura Y., and Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 126 (1996) 3063-3068
45. Roberts P.R., Burney J.D., Black K.W., and Zaloga G.P. Effect of chain length on absorption of biologically active peptides from the gastrointestinal tract. Digestion 60 (1999) 332-337
46. Suetsuna K. Isolation and characterization of angiotensin I converting enzyme inhibitor dipeptides derived from Allium sativum L (garlic). J Nutr Biochem 9 (1998) 415-419
47. Chen H.M., Muramoto K., Yamauchi F., Fujimoto K., and Nokihara K. Antioxidative properties of histidine-containing peptides designed from peptide fragments found in the digests of a soybean protein. J Agric Food Chem 46 (1998) 49-53
48. Pena-Ramos E.A., Xiong Y.L., and Arteaga G.E. Fractionation and characterisation for antioxidant activity of hydrolysed whey protein. J Sci Food Agric 84 (2004) 1908-1918
49. Chen H.M., Muramoto K., Yamauchi F., and Nokihara K. Antioxidant activity of designed peptides based on the antioxidative peptide isolated from digests of a soybean protein. J Agric Food Chem 44 (1996) 2619-2623
50. Fiat A.M., Levy-Toledano S., Caen J.P., and Jolles P. Biologically active peptides of casein and lactotransferrin implicated in platelet function. J Dairy Res 56 (1989) 351-355
51. Chabance B., Jolles P., Izquierdo C., Mazoyer E., Francoual C., Drouet L., et al. Characterization of an antithrombotic peptide from kappa-casein in newborn plasma after milk ingestion. Br J Nutr 73 (1995) 583-590
52. Wergedahl H., Liaset B., Gudbrandsen O.A., Lied E., Espe M., Muna Z., et al. Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. J Nutr 134 (2004) 1320-1327
53. Morita T., Oh-hashi A., Takei K., Ikai M., Kasaoka S., and Kiriyama S. Cholesterol-lowering effects of soybean, potato and rice proteins depend on their low methionine contents in rats fed a cholesterol-free purified diet. J Nutr 127 (1997) 470-477
54. Kritchevsky D., Tepper S.A., Czarnecki S.K., and Klurfeld D.M. Atherogenicity of animal and vegetable protein. Influence of the lysine to arginine ratio. Atherosclerosis 41 (1982) 429-431
55. Iwami K., Sakakibara K., and Ibuki F. Involvement of post-digestion 'hydrophobic' peptides in plasma cholesterol-lowering effect of dietary plant proteins. Agric Biol Chem 50 (1986) 1217-1222
56. Making S., Nakashima H., Minami K., Moriyama R., and Takao S. Bile acid-binding protein from soybean seed: isolation, partial characterization and insulin-stimulating activity. Agric Biol Chem 52 (1988) 803-809
57. Nishi T., Hara H., Hira T., and Tomita F. Dietary protein peptic hydrolysates stimulate cholecystokinin release via direct sensing by rat intestinal mucosal cells. Exp Biol Med (Maywood) 226 (2001) 1031-1036
58. Nishi T., Hara H., Asano K., and Tomita F. The soybean beta-conglycinin beta 51-63 fragment suppresses appetite by stimulating cholecystokinin release in rats. J Nutr 133 (2003) 2537-2542
59. Fujita H., Usui H., Kurahashi K., and Yoshikawa M. Isolation and characterization of ovokinin, a bradykinin B1 agonist peptide derived from ovalbumin. Peptides 16 (1995) 785-790
60. Matoba N., Usui H., Fujita H., and Yoshikawa M. A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Lett 452 (1999) 181-184
61. Erdmann K., Grosser N., Schipporeit K., and Schroder H. The ACE inhibitory dipeptide Met-Tyr diminishes free radical formation in human endothelial cells via induction of heme oxygenase-1 and ferritin. J Nutr 136 (2006) 2148-2152
62. Nurminen M.L., Sipola M., Kaarto H., Pihlanto-Leppala A., Piilola K., Korpela R., et al. Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci 66 (2000) 1535-1543
63. Yamamoto N., Maeno M., and Takano T. Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J Dairy Sci 82 (1999) 1388-1393
64. Ames B.N., Shigenaga M.K., and Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 90 (1993) 7915-7922
65. Steinbrecher U.P., Zhang H.F., and Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 9 (1990) 155-168
66. Witztum J.L., and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88 (1991) 1785-1792
67. Machlin L.J., and Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. J Faseb 1 (1987) 441-445
68. de Lorgeril M., Salen P., Monjaud I., and Delaye J. The 'diet heart' hypothesis in secondary prevention of coronary heart disease. Eur Heart J 18 (1997) 13-18
69. Fang Y.Z., Yang S., and Wu G. Free radicals, antioxidants, and nutrition. Nutrition 18 (2002) 872-879
70. Simopoulos A.P. The Mediterranean diets: What is so special about the diet of Greece? The scientific evidence. J Nutr 131 (2001) 3065S-3073S
71. Suetsuna K., Ukeda H., and Ochi H. Isolation and characterization of free radical scavenging activities peptides derived from casein. J Nutr Biochem 11 (2000) 128-131
72. Hernandez-Ledesma B., Davalos A., Bartolome B., and Amigo L. Preparation of antioxidant enzymatic hydrolysates from alpha-lactalbumin and beta-lactoglobulin. Identification of active peptides by HPLC-MS/MS. J Agric Food Chem 53 (2005) 588-593
73. Davalos A., Miguel M., Bartolome B., and Lopez-Fandino R. Antioxidant activity of peptides derived from egg white proteins by enzymatic hydrolysis. J Food Prot 67 (2004) 1939-1944
74. Ishikawa S., Yano Y., Arihara K., and Itoh M. Egg yolk phosvitin inhibits hydroxyl radical formation from the fenton reaction. Biosci Biotechnol Biochem 68 (2004) 1324-1331
75. Chen H.M., Muramoto K., and Yamauchi F. Structural analysis of antioxidative peptides from soybean beta-conglycinin. J Agric Food Chem 43 (1995) 574-578
76. Park P.J., Jung W.K., Nam K.S., Shahidi F., and Kim S.K. Purification and characterization of antioxidative peptides from protein hydrolysate of lecithin-free egg yolk. J Am Oil Chem Soc 78 (2001) 651-656
77. Rival S.G., Boeriu C.G., and Wichers H.J. Caseins and casein hydrolysates: 2. Antioxidative properties and relevance to lipoxygenase inhibition. J Agric Food Chem 49 (2001) 295-302
78. Saiga A., Tanabe S., and Nishimura T. Antioxidant activity of peptides obtained from porcine myofibrillar proteins by protease treatment. J Agric Food Chem 51 (2003) 3661-3667
79. Abraham N.G., Lin J.H., Schwartzman M.L., Levere R.D., and Shibahara S. The physiological significance of heme oxygenase. Int J Biochem 20 (1988) 543-558
80. Tenhunen R., Marver H.S., and Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 61 (1968) 748-755
81. Coceani F. Carbon monoxide in vasoregulation: the promise and the challenge. Circ Res 86 (2000) 1184-1186
82. Hopkins P.N., Wu L.L., Hunt S.C., James B.C., Vincent G.M., and Williams R.R. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 16 (1996) 250-255
83. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 46 (2000) 1723-1727
84. Eisenstein R.S., Garcia_Mayol D., Pettingell W., and Munro H.N. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci U S A 88 (1991) 688-692
85. Rival S.G., Fornaroli S., Boeriu C.G., and Wichers H.J. Caseins and casein hydrolysates: 1. Lipoxygenase inhibitory properties. J Agric Food Chem 49 (2001) 287-294
86. Chan K.M., and Decker E.A. Endogenous skeletal muscle antioxidants. Crit Rev Food Sci Nutr 34 (1994) 403-426
87. Alabovsky V.V., Boldyrev A.A., Vinokurov A.A., and Shchavratsky V. Effect of histidine-containing dipeptides on isolated heart under ischemia/reperfusion. Biochemistry (Mosc) 62 (1997) 77-87
88. Takenaka A., Annaka H., Kimura Y., Aoki H., and Igarashi K. Reduction of paraquat-induced oxidative stress in rats by dietary soy peptide. Biosci Biotechnol Biochem 67 (2003) 278-283
89. Nagasawa T., Yonekura T., Nishizawa N., and Kitts D.D. In vitro and in vivo inhibition of muscle lipid and protein oxidation by carnosine. Mol Cell Biochem 225 (2001) 29-34
90. Laakso S. Inhibition of lipid peroxidation by casein. Evidence of molecular encapsulation of 1,4-pentadiene fatty acids. Biochim Biophys Acta 792 (1984) 11-15
91. Bertina R.M. Molecular risk factors for thrombosis. Thromb Haemost 82 (1999) 601-609
92. Grundy S.M., Balady G.J., Criqui M.H., Fletcher G., Greenland P., Hiratzka L.F., et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 97 (1998) 1876-1887
93. Jolles P. Structural aspects of the milk clotting process. Comparative features with the blood clotting process. Mol Cell Biochem 7 (1975) 73-85
94. Qian Z.Y., Jolles P., Migliore-Samour D., Schoentgen F., and Fiat A.M. Sheep kappa-casein peptides inhibit platelet aggregation. Biochim Biophys Acta 1244 (1995) 411-417
95. Jolles P., Levy-Toledano S., Fiat A.M., Soria C., Gillessen D., Thomaidis A., et al. Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from kappa-casein on platelet function. Eur J Biochem 158 (1986) 379-382
96. Raha S., Dosquet C., Abgrall J.F., Jolles P., Fiat A.M., and Caen J.P. KRDS - a tetrapeptide derived from lactotransferrin-inhibits binding of monoclonal antibody against glycoprotein IIb-IIIa on ADP-stimulated platelets and megakaryocytes. Blood 72 (1988) 172-178
97. Mazoyer E., Levy-Toledano S., Rendu F., Hermant L., Lu H., Fiat A.M., et al. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction. Eur J Biochem 194 (1990) 43-49
98. Drouet L., Bal dit Sollier C., Cisse M., Pignaud G., Mazoyer E., Fiat A.M., et al. The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RGDS. Nouv Rev Fr Hematol 32 (1990) 59-62
99. Maubois J.L., Leonil J., Trouve R., and Bouhallab S. Milk peptides with physiological activities: III. Peptides with a cardiovascular effect: antithrombotic and antihypertensive activity. Lait 71 (1991) 249-255
100. Rutherfurd K.J., and Gill H.S. Peptides affecting coagulation. Br J Nutr 84 Suppl 1 (2000) S99-S102
101. Hokanson J.E., and Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3 (1996) 213-219
102. Martin M.J., Hulley S.B., Browner W.S., Kuller L.H., and Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 2 (1986) 933-936
103. Hori G., Wang M.F., Chan Y.C., Komatsu T., Wong Y., Chen T.H., et al. Soy protein hydrolyzate with bound phospholipids reduces serum cholesterol levels in hypercholesterolemic adult male volunteers. Biosci Biotechnol Biochem 65 (2001) 72-78
104. Sugano M., Goto S., Yamada Y., Yoshida K., Hashimoto Y., Matsuo T., et al. Cholesterol-lowering activity of various undigested fractions of soybean protein in rats. J Nutr 120 (1990) 977-985
105. Zhang X., and Beynen A.C. Lowering effect of dietary milk-whey protein v. casein on plasma and liver cholesterol concentrations in rats. Br J Nutr 70 (1993) 139-146
106. Nagaoka S., Kanamaru Y., Kojima T., and Kuwata T. Comparative studies on the serum cholesterol lowering action of whey protein and soybean protein in rats. Biosci Biotechnol Biochem 56 (1992) 1484-1485
107. Carroll K.K., and Hamilton R.M.G. Effects of dietary protein and carbohydrate on plasma cholesterol levels in relation to atherosclerosis. J Food Sci 40 (1975) 18-23
108. Van der Meer R., De Vries H.T., and Van Tintelen G. The phosphorylation state of casein and the species-dependency of its hypercholesterolaemic effect. Br J Nutr 59 (1988) 467-473
109. Potter S.M. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 125 (1995) 606S-611S
110. Nagata Y., Ishiwaki N., and Sugano M. Studies on the mechanism of antihypercholesterolemic action of soy protein and soy protein-type amino acid mixtures in relation to the casein counterparts in rats. J Nutr 112 (1982) 1614-1625
111. Huff M.W., and Carroll K.K. Effects of dietary proteins and amino acid mixtures on plasma cholesterol levels in rabbits. J Nutr 110 (1980) 1676-1685
112. Wang M.F., Yamamoto S., Chung H.M., Chung S.Y., Miyatani S., Mori M., et al. Antihypercholesterolemic effect of undigested fraction of soybean protein in young female volunteers. J Nutr Sci Vitaminol (Tokyo) 41 (1995) 187-195
113. Yoshikawa M., Fujita H., Matoba N., Takenaka Y., Yamamoto T., Yamauchi R., et al. Bioactive peptides derived from food proteins preventing lifestyle-related diseases. Biofactors 12 (2000) 143-146
114. Takenaka Y., Utsumi S., and Yoshikawa M. Introduction of enterostatin (VPDPR) and a related sequence into soybean proglycinin A1aB1b subunit by site-directed mutagenesis. Biosci Biotechnol Biochem 64 (2000) 2731-2733
115. Pak V.V., Koo M.S., Kasymova T.D., and Kwon D.Y. Isolation and identification of peptides from soy 11S-globulin with hypocholesterolemic activity. Chem Nat Compd 41 (2005) 710-714
116. Pak V.V., Koo M., Lee N., Kim M.S., and Kwon D.Y. Structure-activity relationships of the peptide Ile-Ala-Val-Pro and its derivatives revealed using the semi-empirical AM1 method. Chem Nat Compd 41 (2005) 454-460
117. Lovati M.R., Manzoni C., Gianazza E., Arnoldi A., Kurowska E., Carroll K.K., et al. Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J Nutr 130 (2000) 2543-2549
118. Duranti M., Lovati M.R., Dani V., Barbiroli A., Scarafoni A., Castiglioni S., et al. The alpha′ subunit from soybean 7S globulin lowers plasma lipids and upregulates liver beta-VLDL receptors in rats fed a hypercholesterolemic diet. J Nutr 134 (2004) 1334-1339
119. Iritani N., Nagashima K., Fukuda H., Katsurada A., and Tanaka T. Effects of dietary proteins on lipogenic enzymes in rat liver. J Nutr 116 (1986) 190-197
120. Iritani N., Hosomi H., Fukuda H., Tada K., and Ikeda H. Soybean protein suppresses hepatic lipogenic enzyme gene expression in Wistar fatty rats. J Nutr 126 (1996) 380-388
121. Moriyama T., Kishimoto K., Nagai K., Urade R., Ogawa T., Utsumi S., et al. Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption. Biosci Biotechnol Biochem 68 (2004) 352-359
122. Kagawa K., Matsutaka H., Fukuhama C., Watanabe Y., and Fujino H. Globin digest, acidic protease hydrolysate, inhibits dietary hypertriglyceridemia and Val-Val-Tyr-Pro, one of its constituents, possesses most superior effect. Life Sci 58 (1996) 1745-1755
123. Kagawa K., Matsutaka H., Fukuhama C., Fujino H., and Okuda H. Suppressive effect of globin digest on postprandial hyperlipidemia in male volunteers. J Nutr 128 (1998) 56-60
124. Nagaoka S. Studies on regulation of cholesterol metabolism induced by dietary food constituents or xenobiotics. J Jpn Soc Nutr Food Sci 49 (1996) 303-313
125. Nagaoka S., Kanamaru Y., and Kuzuya Y. Effect of whey protein and casein on the plasma and liver lipid in rats. Agric Biol Chem 55 (1991) 813-818
126. Nagaoka S., Futamura Y., Miwa K., Awano T., Yamauchi K., Kanamaru Y., et al. Identification of novel hypocholesterolemic peptides derived from bovine milk beta-lactoglobulin. Biochem Biophys Res Commun 281 (2001) 11-17
127. Morikawa K., Kondo I., Kanamaru Y., and Nagaoka S. A novel regulatory pathway for cholesterol degradation via lactostatin. Biochem Biophys Res Commun 352 (2007) 697-702
128. Hubert H.B., Feinleib M., McNamara P.M., and Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 (1983) 968-977
129. Howard B.V. Insulin resistance and lipid metabolism. Am J Cardiol 84 (1999) 28J-32J
130. Krauss R.M., Winston M., Fletcher R.N., and Grundy S.M. Obesity: impact of cardiovascular disease. Circulation 98 (1998) 1472-1476
131. Anderson G.H., and Moore S.E. Dietary proteins in the regulation of food intake and body weight in humans. J Nutr 134 (2004) 974S-979S
132. Johnstone A.M., Stubbs R.J., and Harbron C.G. Effect of overfeeding macronutrients on day-to-day food intake in man. Eur J Clin Nutr 50 (1996) 418-430
133. Hu F.B. Protein, body weight, and cardiovascular health. Am J Clin Nutr 82 (2005) 242S-247S
134. Aoyama T., Fukui K., Nakamori T., Hashimoto Y., Yamamoto T., Takamatsu K., et al. Effect of soy and milk whey protein isolates and their hydrolysates on weight reduction in genetically obese mice. Biosci Biotechnol Biochem 64 (2000) 2594-2600
135. Aoyama T., Fukui K., Takamatsu K., Hashimoto Y., and Yamamoto T. Soy protein isolate and its hydrolysate reduce body fat of dietary obese rats and genetically obese mice (yellow KK). Nutrition 16 (2000) 349-354
136. Belobrajdic D.P., McIntosh G.H., and Owens J.A. A high-whey-protein diet reduces body weight gain and alters insulin sensitivity relative to red meat in Wistar rats. J Nutr 134 (2004) 1454-1458
137. Pupovac J., and Anderson G.H. Dietary peptides induce satiety via cholecystokinin-A and peripheral opioid receptors in rats. J Nutr 132 (2002) 2775-2780
138. Baile C.A., McLaughlin C.L., and Della-Fera M.A. Role of cholecystokinin and opioid peptides in control of food intake. Physiol Rev 66 (1986) 172-234
139. Reidelberger R.D. Cholecystokinin and control of food intake. J Nutr 124 (1994) 1327S-1333S
140. Nishi T., Hara H., and Tomita F. Soybean beta-conglycinin peptone suppresses food intake and gastric emptying by increasing plasma cholecystokinin levels in rats. J Nutr 133 (2003) 352-357
141. Nishi T., Hara H., and Kasai T. Guanidinated casein hydrolysate stimulates pancreatic secretagogue release by direct action to the intestine in rats. Proc Soc Exp Biol Med 218 (1998) 357-364
142. Froetschel M.A., Azain M.J., Edwards G.L., Barb C.R., and Amos H.E. Opioid and cholecystokinin antagonists alleviate gastric inhibition of food intake by premeal loads of casein in meal-fed rats. J Nutr 131 (2001) 3270-3276
143. Pedersen N.L., Nagain-Domaine C., Mahe S., Chariot J., Roze C., and Tome D. Caseinomacropeptide specifically stimulates exocrine pancreatic secretion in the anesthetized rat. Peptides 21 (2000) 1527-1535
144. Beucher S., Levenez F., Yvon M., and Corring T. Effects of gastric digestive products from casein on CCK release by intestinal cells in rat. J Nutr Biochem 5 (1994) 578-584
145. Daniel H., Vohwinkel M., and Rehner G. Effect of casein and beta-casomorphins on gastrointestinal motility in rats. J Nutr 120 (1990) 252-257
146. Schusdziarra V., Schick A., de la Fuente A., Specht J., Klier M., Brantl V., et al. Effect of beta-casomorphins and analogs on insulin release in dogs. Endocrinology 112 (1983) 885-889
147. Clare D.A., and Swaisgood H.E. Bioactive milk peptides: a prospectus. J Dairy Sci 83 (2000) 1187-1195
148. Beucher S., Levenez F., Yvon M., and Corring T. Effect of caseinomacropeptide (CMP) on cholecystokinin (CCK) release in rat. Reprod Nutr Dev 34 (1994) 613-614
149. Aziz A., and Anderson G.H. Exendin-4, a GLP-1 receptor agonist, interacts with proteins and their products of digestion to suppress food intake in rats. J Nutr 133 (2003) 2326-2330
150. Hall W.L., Millward D.J., Long S.J., and Morgan L.M. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 89 (2003) 239-248
151. Cordier-Bussat M., Bernard C., Levenez F., Klages N., Laser-Ritz B., Philippe J., et al. Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene. Diabetes 47 (1998) 1038-1045
152. Nagasawa A., Fukui K., Funahashi T., Maeda N., Shimomura I., Kihara S., et al. Effects of soy protein diet on the expression of adipose genes and plasma adiponectin. Horm Metab Res 34 (2002) 635-639
153. Velasquez M.T., and Bhathena S.J. Role of dietary soy protein in obesity. Int J Med Sci 4 (2007) 72-82
154. Ascencio C., Torres N., Isoard_Acosta F., Gomez_Perez F.J., Hernandez_Pando R., and Tovar A.R. Soy protein affects serum insulin and hepatic SREBP_1 mRNA and reduces fatty liver in rats. J Nutr 134 (2004) 522-529